Talimogene Laherparepvec and Nivolumab in Treating Patients With Refractory Lymphomas or Advanced or Refractory Non-melanoma Skin Cancers
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Prescient Therapeutics, Ltd.
City of Hope Medical Center
UNC Lineberger Comprehensive Cancer Center
University of Pittsburgh
Fondazione Italiana Linfomi - ETS
Fondazione Italiana Linfomi - ETS
UNC Lineberger Comprehensive Cancer Center
City of Hope Medical Center
Assistance Publique - Hôpitaux de Paris
Kyowa Kirin Co., Ltd.
SciTech Development, Inc.
City of Hope Medical Center
Barbara Ann Karmanos Cancer Institute
UNC Lineberger Comprehensive Cancer Center
City of Hope Medical Center
Memorial Sloan Kettering Cancer Center
Thomas Jefferson University